methylselenic acid has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Studies (methylselenic acid) | Trials (methylselenic acid) | Recent Studies (post-2010) (methylselenic acid) | Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) |
|---|---|---|---|---|---|
| 144 | 1 | 68 | 7 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcolea, V; Encío, I; Palop, JA; Plano, D; Sanmartín, C; Sharma, AK | 1 |
1 other study(ies) available for methylselenic acid and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Chalcogens; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Structure-Activity Relationship | 2016 |